BACKGROUND: The largest-ever outbreak of Ebola virus disease (EVD), ongoing in West Africa since late 2013, has led to export of cases to Europe and North America. Clinicians encountering ill travelers arriving from countries with widespread Ebola virus transmission must be aware of alternate diagnoses associated with fever and other nonspecific symptoms. OBJECTIVE: To define the spectrum of illness observed in persons returning from areas of West Africa where EVD transmission has been widespread. DESIGN: Descriptive, using GeoSentinel records. SETTING: 57 travel or tropical medicine clinics in 25 countries. PATIENTS: 805 ill returned travelers and new immigrants from Sierra Leone, Liberia, or Guinea seen between September 2009 and August 2014. MEASUREMENTS: Frequencies of demographic and travel-related characteristics and illnesses reported. RESULTS: The most common specific diagnosis among 770 nonimmigrant travelers was malaria (n = 310 [40.3%]), with Plasmodium falciparum or severe malaria in 267 (86%) and non-P. falciparum malaria in 43 (14%). Acute diarrhea was the second most common diagnosis among nonimmigrant travelers (n = 95 [12.3%]). Such common diagnoses as upper respiratory tract infection, urinary tract infection, and influenza-like illness occurred in only 26, 9, and 7 returning travelers, respectively. Few instances of typhoid fever (n = 8), acute HIV infection (n = 5), and dengue (n = 2) were encountered. LIMITATION: Surveillance data collected by specialist clinics may not be representative of all ill returned travelers. CONCLUSION: Although EVD may currently drive clinical evaluation of ill travelers arriving from Sierra Leone, Liberia, and Guinea, clinicians must be aware of other more common, potentially fatal diseases. Malaria remains a common diagnosis among travelers seen at GeoSentinel sites. Prompt exclusion of malaria and other life-threatening conditions is critical to limiting morbidity and mortality. PRIMARY FUNDING SOURCE: Centers for Disease Control and Prevention.
BACKGROUND: The largest-ever outbreak of Ebola virus disease (EVD), ongoing in West Africa since late 2013, has led to export of cases to Europe and North America. Clinicians encountering ill travelers arriving from countries with widespread Ebola virus transmission must be aware of alternate diagnoses associated with fever and other nonspecific symptoms. OBJECTIVE: To define the spectrum of illness observed in persons returning from areas of West Africa where EVD transmission has been widespread. DESIGN: Descriptive, using GeoSentinel records. SETTING: 57 travel or tropical medicine clinics in 25 countries. PATIENTS: 805 ill returned travelers and new immigrants from Sierra Leone, Liberia, or Guinea seen between September 2009 and August 2014. MEASUREMENTS: Frequencies of demographic and travel-related characteristics and illnesses reported. RESULTS: The most common specific diagnosis among 770 nonimmigrant travelers was malaria (n = 310 [40.3%]), with Plasmodium falciparum or severe malaria in 267 (86%) and non-P. falciparum malaria in 43 (14%). Acute diarrhea was the second most common diagnosis among nonimmigrant travelers (n = 95 [12.3%]). Such common diagnoses as upper respiratory tract infection, urinary tract infection, and influenza-like illness occurred in only 26, 9, and 7 returning travelers, respectively. Few instances of typhoid fever (n = 8), acute HIV infection (n = 5), and dengue (n = 2) were encountered. LIMITATION: Surveillance data collected by specialist clinics may not be representative of all ill returned travelers. CONCLUSION: Although EVD may currently drive clinical evaluation of ill travelers arriving from Sierra Leone, Liberia, and Guinea, clinicians must be aware of other more common, potentially fatal diseases. Malaria remains a common diagnosis among travelers seen at GeoSentinel sites. Prompt exclusion of malaria and other life-threatening conditions is critical to limiting morbidity and mortality. PRIMARY FUNDING SOURCE: Centers for Disease Control and Prevention.
Authors: Karin Leder; Steven Tong; Leisa Weld; Kevin C Kain; Annelies Wilder-Smith; Frank von Sonnenburg; Jim Black; Graham V Brown; Joseph Torresi Journal: Clin Infect Dis Date: 2006-09-26 Impact factor: 9.079
Authors: Daniel S Chertow; Christian Kleine; Jeffrey K Edwards; Roberto Scaini; Ruggero Giuliani; Armand Sprecher Journal: N Engl J Med Date: 2014-11-05 Impact factor: 91.245
Authors: David O Freedman; Leisa H Weld; Phyllis E Kozarsky; Tamara Fisk; Rachel Robins; Frank von Sonnenburg; Jay S Keystone; Prativa Pandey; Martin S Cetron Journal: N Engl J Med Date: 2006-01-12 Impact factor: 91.245
Authors: Victoria Johnston; Jane M Stockley; David Dockrell; David Warrell; Robin Bailey; Geoffrey Pasvol; John Klein; Andrew Ustianowski; Michael Jones; Nicholas J Beeching; Michael Brown; Ann L N Chapman; Frances Sanderson; Christopher J M Whitty Journal: J Infect Date: 2009-05-27 Impact factor: 6.072
Authors: M A Bwaka; M J Bonnet; P Calain; R Colebunders; A De Roo; Y Guimard; K R Katwiki; K Kibadi; M A Kipasa; K J Kuvula; B B Mapanda; M Massamba; K D Mupapa; J J Muyembe-Tamfum; E Ndaberey; C J Peters; P E Rollin; E Van den Enden; E Van den Enden Journal: J Infect Dis Date: 1999-02 Impact factor: 5.226
Authors: Mary E Wilson; Leisa H Weld; Andrea Boggild; Jay S Keystone; Kevin C Kain; Frank von Sonnenburg; Eli Schwartz Journal: Clin Infect Dis Date: 2007-05-07 Impact factor: 9.079
Authors: Aura Timen; Marion P G Koopmans; Ann C T M Vossen; Gerard J J van Doornum; Stephan Günther; Franchette van den Berkmortel; Kees M Verduin; Sabine Dittrich; Petra Emmerich; Albert D M E Osterhaus; Jaap T van Dissel; Roel A Coutinho Journal: Emerg Infect Dis Date: 2009-08 Impact factor: 6.883
Authors: Ann Winters; Maryam Iqbal; Isaac Benowitz; Jennifer Baumgartner; Neil M Vora; Laura Evans; Nate Link; Iona Munjal; Belinda Ostrowsky; Joel Ackelsberg; Sharon Balter; Catherine Dentinger; Anne D Fine; Scott Harper; Keren Landman; Fabienne Laraque; Marcelle Layton; Sally Slavinski; Don Weiss; Jennifer L Rakeman; Scott Hughes; Jay K Varma; Ellen H Lee Journal: Public Health Rep Date: 2019-08-19 Impact factor: 2.792
Authors: Jessica K Fairley; Phyllis E Kozarsky; Colleen S Kraft; Jeannette Guarner; James P Steinberg; Evan Anderson; Jesse T Jacob; Patrick Meloy; Darria Gillespie; Tamara R Espinoza; Alexander Isakov; Sharon Vanairsdale; Esther Baker; Henry M Wu Journal: Open Forum Infect Dis Date: 2016-01-18 Impact factor: 3.835
Authors: Aleksandra Leligdowicz; William A Fischer; Timothy M Uyeki; Thomas E Fletcher; Neill K J Adhikari; Gina Portella; Francois Lamontagne; Christophe Clement; Shevin T Jacob; Lewis Rubinson; Abel Vanderschuren; Jan Hajek; Srinivas Murthy; Mauricio Ferri; Ian Crozier; Elhadj Ibrahima; Marie-Claire Lamah; John S Schieffelin; David Brett-Major; Daniel G Bausch; Nikki Shindo; Adrienne K Chan; Tim O'Dempsey; Sharmistha Mishra; Michael Jacobs; Stuart Dickson; G Marshall Lyon; Robert A Fowler Journal: Crit Care Date: 2016-07-29 Impact factor: 9.097
Authors: Himiede W Wilson; Maame Amo-Addae; Ernest Kenu; Olayinka Stephen Ilesanmi; Donne K Ameme; Samuel O Sackey Journal: Biomed Res Int Date: 2018-06-28 Impact factor: 3.411